Results 211 to 220 of about 64,132 (250)
Some of the next articles are maybe not open access.

Underdiagnosis of Isolated Systolic and Isolated Diastolic Hypertension

The American Journal of Cardiology, 2021
Systolic and diastolic hypertension independently predict the risk of adverse cardiovascular events. It remains unclear how systolic pressure, diastolic pressure, and other patient characteristics influence the initial diagnosis of hypertension. Here, we use a cohort of 146,816 adults in a large healthcare system to examine how elevated systolic and/or
Carol Conell   +8 more
openaire   +2 more sources

Isolated systolic hypertension

Journal of Hypertension, 2004
The prevalence of essential hypertension is very high in Western Countries and isolated systolic hypertension (ISH) is the peculiar form of older patients. ISH was considered a physiological condition until the '80s and it was recognised as a real disease only in the '90s, when the efficacy of pharmacological treatments in terms of cardiovascular ...
Ungar A.   +5 more
openaire   +3 more sources

Treatment of isolated systolic hypertension

Current Hypertension Reports, 2006
Isolated systolic hypertension (ISH) is the dominant form of hypertension in the elderly. It is associated with increased arterial pulse pressure, to which an early-returning and magnified pulse-wave reflection makes an important contribution. Treatment of ISH with diuretics, calcium channel blockers (CCBs), and angiotensin II inhibitors is effective ...
openaire   +2 more sources

Treatment of Isolated Systolic Hypertension in the Elderly

Journal of Cardiovascular Pharmacology, 1991
Isolated systolic hypertension affects between 10 and 20% of the elderly population and carries a substantial risk of cardiovascular complications. As no prospective, randomized trials have produced scientific evidence of a treatment benefit in elderly patients with isolated systolic hypertension, opinion on when and how to treat this condition differs
J, Staessen   +6 more
openaire   +2 more sources

Clinical trials in isolated systolic hypertension

Current Hypertension Reports, 1999
Isolated systolic hypertension affects 8% to 15% of all people older than 60 years of age. In the elderly, systolic hypertension is the major modifiable cardiovascular risk factor. Three placebo-controlled outcome trials on antihypertensive drug treatment of this disorder have been published.
J, Gasowski, J G, Wang, J A, Staessen
openaire   +2 more sources

Isolated Systolic Hypertension

2017
ISH is diagnosed when systolic blood pressure is more than 140 mmHg with a normal or low diastolic pressure (less than 90 mmHg). Prevalence of ISH increases with age, and it is one of the special problems in hypertension among geriatric population. Contrary to traditional thinking, systolic hypertension is a strong predictor of cardiovascular
openaire   +1 more source

Isolated Systolic Hypertension

Archives of Internal Medicine, 1994
UNTIL RECENTLY, whenever I lectured on hypertension I could expect to be frustrated by my inability to answer questions about isolated systolic hypertension (ISH) with authority derived from a scientific database. Indeed, it is not that many years ago that systolic blood pressure was considered to be normal if it were less than the patient's age plus ...
openaire   +1 more source

Determinants of isolated systolic hypertension in the elderly

Journal of Hypertension, 1992
To study the determinants (or mechanisms) of isolated systolic hypertension in the elderly.Pulsatile blood pressure and flow (multisensor catheter) were measured in the ascending aorta and impedance spectra were calculated in 18 subjects undergoing cardiac catheterization. Nine subjects (mean +/- SEM age 58 +/- 1.4 years) had increased aortic systolic (
W W, Nichols, F A, Nicolini, C J, Pepine
openaire   +2 more sources

Trials in isolated systolic hypertension: An update

Current Cardiology Reports, 2003
Isolated systolic hypertension (ISH) has proved to be a powerful predisposing factor for cardiovascular diseases in the elderly. Recent placebo-controlled interventional trials such as the Systolic Hypertension in the Elderly Program (SHEP), the Systolic Hypertension in Europe (Syst-Eur), and the Systolic Hypertension in China (Syst-China) showed that ...
openaire   +5 more sources

Treating Isolated Systolic Hypertension in the Elderly

Annals of Pharmacotherapy, 1994
OBJECTIVE: To review the prevalence, pathophysiology, vascular risk, and treatment of isolated systolic hypertension (ISH) in the elderly. DATA SOURCE: A MEDLINE search of the English language literature was performed to identify ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy